Le zinc viendra-t-il à bout du rhume?: revue Cochrane pour le praticien.

Cet article présente les résultats de la revue systématique: Singh M, Das RR. Zinc for the common cold. Cochrane Database of Systematic Reviews 2011, Issue 2, Art. No.: CD001364. DOI: 10.1002/14651858.CD001364.pub3. PMID: 21328251.

Lagrimo occhi mici : air / Sigismont d'India, comp. ; réalisation Claude Crussard. Ohimé dov' e il mio ben : madrigal ; Maledetto... [etc.] / Monteverdi, comp. ; réalisation Claude Crussard ; Maria Castellazzi, Leïla Ben Sedira, S ; Ensemble instrumental Ars Rediviva

Comprend : Lagrimo occhi mici / Sigismont d'India, comp. ; réalisation Claude Crussard ; Maria Castellazzi, Leïla Ben Sedira, S ; Ensemble instrumental Ars Rediviva ; Ohimè, dov'è il mio ben ? / Monteverdi, comp. ; réalisation Claude Crussard ; Maria Castellazzi, Leïla Ben Sedira, S ; Ensemble instrumental Ars Rediviva ; Maledetto sia l'aspetto / Monteverdi, comp. ; réalisation Claude Crussard ; Maria Castellazzi, Leïla Ben Sedira, S ; Ensemble instrumental Ars Rediviva ; Chiome d'oro, bel thesoro / Monteverdi, comp. ; réalisation Claude Crussard ; Maria Castellazzi, Leïla Ben Sedira, S ; Ensemble instrumental Ars Rediviva

Conquiste della Serenissima Republica di Venetia nella Moreasotto il comando del doge Francesco Morosini / Descritte, e dedicate all illustrissimo et eccellentissimo signore il signore Domenico Contarini, ... ; Alla Santità di N. S. Innocenzo XII ; Dal Padre Cosmografo Coronelli

Échelle(s) : [Echelles diverses]

Jugement... de la capitainerie royale de Senart qui condamne le nommé Rognon, berger à Gravois, en 50 livres d'amende, pour avoir porté et tiré plusieurs fois nuitamment un fusil dont il a été trouvé muni. Ordonne que la veuve Langlois, fermière audit Gravois, sera solidairement tenue de ladite amende

[Acte. 1781-10-12. Montgeron]

Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.

BACKGROUND: Exclusive liver metastases occur in up to 40% of patients with uveal melanoma associated with a median survival of 2-7 months. Single agent response rates with commonly available chemotherapy are below 10%. We have investigated the use of fotemustine via direct intra-arterial hepatic (i.a.h.) administration in patients with uveal melanoma metastases. PATIENTS AND METHODS: A total of 101 patients from seven centers were treated with i.a.h. fotemustine, administered intra-arterially weekly for a 4-week induction period, and then as a maintenance treatment every 3 weeks until disease progression, unacceptable toxicity or patient refusal. RESULTS: A median of eight fotemustine infusions per patient were delivered (range 1-26). Catheter related complications occurred in 23% of patients; however, this required treatment discontinuation in only 10% of the patients. The overall response rate was 36% with a median overall survival of 15 months and a 2-year survival rate of 29%. LDH, time between diagnosis and treatment start and gender were significant predictors of survival. CONCLUSIONS: Locoregional treatment with fotemustine is well tolerated and seems to improve outcome of this poor prognosis patient population. Median survival rates are among the longest reported and one-third of the patients are still alive at 2 years.